Briefly, OT1 T cells were mixed with previously plated OVA expressing B16 melanoma target cells at a known ratio and anti-CD8 mAbs were added at various concentrations along with an active caspase-3/7 fluorescent dye. This evidence concerns the gene CD8A and melanoma.